Skip to content
Shared Decision Making in Relapsed/Refractory Mantle Cell Lymphoma episode artwork

Sep 24, 2024 8 min

Shared Decision Making in Relapsed/Refractory Mantle Cell Lymphoma

from CANCER BUZZ

The range of frontline therapy options for mantle cell lymphoma can influence subsequent treatment choices for patients with relapsed or refractory disease. Providers must determine initial treatment based on individual patient characteristics, while also factoring in future treatment options. In this episode, CANCER BUZZ speaks with Nirav Shah, MD, MSHP, associate professor of medicine at Medical College of Wisconsin and Kirollos Hanna, PharmD, BCOP, PCOP, FACCC, assistant professor of pharmacy at Mayo Clinic and director of pharmacy at Minnesota Oncology, about shared decision making in the management of relapsed or refractory mantle cell lymphoma. "The key to all of this is good collaboration between the community and their affiliates… their partners and academics, or tertiary referral centers, to really engage… these patients in a collaborative format… it really takes a team, a village, to take care of complex mantle cell lymphoma patients. " –Dr. Nirav Shah, MD, MSHP "We're not really seeing a lot of CAR T-cell therapy move in the frontline setting just yet, while there are a lot of ongoing clinical trials… Really, right now, it's going to be the patient characteristic: how well they did on frontline therapy, access to care, affordability, institutional preparedness… that would potentially… allow your patient to receive CAR T-cell therapy." –Kirollos Hanna, PharmD, BCPS, PCOP, FACCC Nirav Shah, MD, MSHP Associate Professor of Medicine Medical College of Wisconsin Division of Hematology and Oncology Milwaukee, Wisconsin Kirollos Hanna, PharmD, BCPS, PCOP, FACCC Assistant Professor of Pharmacy, Mayo Clinic Director of Pharmacy Minnesota Oncology St. Paul, Minnesota This project is made possible by funding and support provided by Eli Lilly and in collaboration with The Leukemia & Lymphoma Society. Resources Treatment for Relapsed/Refractory Mantle Cell Lymphoma Tip Sheet - ACCC Relapsed/Refractory Mantle Cell Lymphoma Educational Video Series: Update on New Therapies: https://vimeo.com/942756449 BTK Inhibitors in MCL: https://vimeo.com/942755401 R/R MCL Case Studies: https://vimeo.com/942754652 BTK Inhibitors Stretch Frontline Approaches in Mantle Cell Lymphoma – Targeted Oncology Emerging Data Continue to Affect BTK Inhibitor Usage in Mantle Cell Lymphoma - OncLive HCP Fact Sheet: Facts About CAR T-cell Therapy - https://www.lls.org/sites/default/files/2023-10/FSHP1_CART_Factsheet_June2022_rev.pdf The CAR T-cell Therapy Process - https://www.lls.org/sites/default/files/2024-03/PS100_CART-CellTherapyProcessFlyer_0224.pdf Patient-Caregiver CAR T-cell Therapy Facts - https://www.lls.org/sites/default/files/2024-04/FS27_CART_Fact_Sheet_0424_rev.pdf Learn About CAR T-cell Therapy - https://www.lls.org/sites/default/files/2024-03/PS126_CART_ResourceCard_3_24.pdf Mantle Cell Lymphoma Facts for Patients and Caregivers -The Leukemia & Lymphoma Society https://lls.org/sites/default/files/2023-08/FS4_Mantle_Cell_Facts_0423rev.pdf

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Shared Decision Making in Relapsed/Refractory Mantle Cell Lymphoma

0:00 8:21

No transcript yet.

Requests help us decide what to transcribe next.

Wild Virginia Old Dominion Eco Buzz Wild Virginia Wild Virginia is a 501(c)(3) nonprofit dedicated to protecting and connecting your favorite wild places. Through partnerships with other environmental advocacy groups we:We educate citizens, landowners, and other stakeholders about threats to our forests through hikes, outings and events.We advocate for the connectivity and integrity of Virginia’s forests and waters.We influence decision makers by mobilizing citizens like you. Lung Cancer Update for Nurses Dr Neil Love Featuring one-on-one interviews conducted by Dr Neil Love with national lung cancer clinical investigators and oncology nurses, this series provides practicing clinicians including nurses and nurse practitioners with valuable information and current clinical management strategies that can be applied to optimize patient care. Non-Hodgkin lymphoma – The Bloodline with LLS The Leukemia & Lymphoma Society Being diagnosed with a blood cancer can make you feel like you are alone. The Bloodline with LLS is here to remind you that after a diagnosis, comes hope. Listen in as we speak with experts and patients who will guide us in understanding diagnosis, treatment, and the many resources available to blood cancer patients. Lymphoma – The Bloodline with LLS The Leukemia & Lymphoma Society Being diagnosed with a blood cancer can make you feel like you are alone. The Bloodline with LLS is here to remind you that after a diagnosis, comes hope. Listen in as we speak with experts and patients who will guide us in understanding diagnosis, treatment, and the many resources available to blood cancer patients.

Frequently asked questions

How long is this episode of CANCER BUZZ?

This episode is 8 minutes long.

When was this CANCER BUZZ episode published?

This episode was published on September 24, 2024.

Can I download this CANCER BUZZ episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.